Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Remdesivir
Remdesivir - Credit: lubo.ivanko / DepositPhotos - License: DepositPhotos
Health
Remdesivir
Coronavirus
Covid-19
SARS-CoV-2
RIVM
Ministry of Public Health Welfare and Sports
Mark de Boer
LUMC
Tuesday, October 6, 2020 - 07:31
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Netherlands has shortage of Covid medicine Remdesivir

Dutch hospitals are currently unable to order virus inhibitor Remdesivir, used to treat the coronavirus. The last available doses were sent out on Sunday, public health institute RIVM and the Ministry of Public Health, Welfare and Sports said to Financieele Dagblad.

A spokesperson for the Ministry called the current shortage "very annoying". The Netherlands has been in talks about this with the European Commission for weeks, according to the newspaper. The EU purchases Remdesivir centrally and arranges distribution among the EU member states .

The RIVM and Ministry could not tell FD whether other European countries are also facing a shortage.

Last month, Minister Hugo de Jonge of Public Health said that the Netherlands' healthcare system was well prepared for the second wave of coronavirus infections, specifically mentioning that it was well stocked with Remdesivir. 

Doctors are not yet alarmed by the shortage, according to FD. Mark de Boer, internist-infectiologist at LUMC who is involved in drawing up treatment guidelines for coronavirus patients, called the shortage "unpleasant" but "not a disaster". 

Remdesivir was originally created to treat Ebola. In June, the European drug authorities approved the medicine for coronavirus patients hospitalized with breathing problems. On average, they recover faster after being given Remdesivir.

The studies on how effective the virus inhibitor is on Covid-19 patients are divided. According to Diederik Gommers, head of the Dutch association for intensive care NVIC, about half of the studies are positive and the other half show no difference with the control group. "Because the drug is not harmful, it is still given," he said, according to NOS. 

Follow us:

Latest stories

  • Second case of monkeypox found in the Netherlands: RIVM
  • Reports of development fund fraud increased in 2021
  • Enforcement officers in Utrecht allowed to voluntarily wear bodycams
  • 1 in 6 Dutch homes still lack smoke detectors
  • Netherlands' budget deficit rises to 3.4 percent
  • Silence circles for Ukraine to be held throughout the Netherlands

Top stories

  • Second case of monkeypox found in the Netherlands: RIVM
  • Much unknown about first Dutch monkeypox cases, experts say
  • 17-year-old girl stabbed after Hilversum robbery; bystanders overpower suspect
  • Most buses in Eindhoven and Venlo are not running due to strike
  • Dutch deficit rises to 3.4%, leading to some higher taxes; 30 percent expat benefit reduced
  • First monkeypox case definitively found in Netherlands

© 2012-2022, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content